Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Biocon and Biomm ink exclusive deal to bring Semaglutide to Brazil Biocon Limited (BSE code: 532523, NSE: BIOCON), a leader in global biopharmaceutical innovations, has announced a pivotal licensing… byPallavi MadhirajuApril 17, 2024